logo
Plus   Neg
Share
Email

Alexion Rejects Elliott Recommendation - Quick Facts

Alexion Pharmaceuticals, Inc. (ALXN) said the company has recently engaged in good faith with Elliott Advisors (UK) Limited, an affiliate of Elliott Management, to listen their recommendation that Alexion Pharma immediately launch a proactive sale process. The Board of Alexion Pharma unanimously decided that conducting a proactive sale process would not be in the best interest of shareholders.

Alexion Pharma said its Board considered, among other factors, that it is highly unusual for a biopharmaceutical company of its size to proactively launch a sale process.

Alexion also noted that it has not received any indications of interest to acquire the
company nor it has rejected any such inbound proposals.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Toyota Motor Corp. has invested $394 million in U.S. electric air-taxi startup Joby Aviation as lead investor in the recent $590 million Series C financing. Toyota said it is continuing to leverage emerging technologies to provide "Mobility for All" as the lead investor as part of its transformation into a mobility company. As the world is facing severe consequences of increasing carbon emissions, Microsoft has announced various plans to tackle the issue. The company aims to reduce its own carbon emissions by more than half, and to be carbon negative by 2030. This means the company will remove more carbon than it emits each year. The company further announced a new $1 billion Climate Innovation Fund. With a view to expanding its presence in France, where it has been doing business for more than 100 years, Food and beverage giant Coca-Cola Co. (KO), during the Choose France Summit, announced 1 billion euros of investments in the country over the next five years. Coca-Cola Chairman and CEO James Quincey and President Emmanuel Macron is scheduled to elaborate on the plans in September.
Follow RTT
>